October Pharma S.A.E (CASE: OCPH)
Health Care · Pharmaceuticals · EG
EGP223.92
-0.76% today · +146.4% 1Y
October Pharma S.A.E (CASE: OCPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $102.66M.
Over the last twelve months the share price has gained 146.4%, trading between 82.50 and 341.99.
Tweenvest scores October Pharma S.A.E across four factors: quality 76/100, value 19/100, growth 12/100. Its strongest factor is quality.
OCPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $102.66M
- Revenue (TTM)
- $30.55M
- P/E
- 32.55
- EPS
- 6.88
- Dividend yield
- —
- Beta (5Y)
- 0.73
- 52-week high
- EGP341.99
- 52-week low
- EGP82.50
- Avg volume (3M)
- —
- Shares outstanding
- 24.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Medexus Pharmaceuticals Inc.TSX: MDP | $104.05M | CA$4.72 | -7.81% |
| Polaryx Therapeutics, Inc.NasdaqCM: PLYX | $103.68M | $2.09 | +0.48% |
| Semnur Pharmaceuticals, Inc.OTCPK: SMNR | $103.59M | $0.45 | -24.87% |
| Cumberland Pharmaceuticals Inc.NasdaqGS: CPIX | $103.23M | $6.89 | -3.50% |
| NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo ReszvenytarsasagBUSE: NATURLAND | $100.56M | Ft2,380.00 | -15.00% |
| RaQualia Pharma Inc.TSE: 4579 | $100.51M | ¥609.00 | +0.33% |
| SAMSUNG PHARM. Co., LTD.KOSE: A001360 | $100.15M | ₩1,433.00 | +9.64% |
| Stella Pharma CorporationTSE: 4888 | $100.03M | ¥426.00 | -0.47% |
Figures last refreshed Oct 4, 2026.